FACTANKER
Altamira Therapeutics Ltd.: xbrl:AdjustedWeightedAverageShares
Value
{"unit": "shares", "value": 41803}
Period
2023-01-01 – 2023-12-31
Status
current
Entity
Altamira Therapeutics Ltd.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001213900-25-037199
Retrieved: 2026-08-19T16:24:25.793555+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…
Cite as: FACTANKER,
https://factanker.com/fact/2c080df5-71a0-4f18-981d-1c6744f89a1c
History
supersedes
{"unit": "shares", "value": 45536}
(evidence 0001213900-24-034940)